Clinical Trial Update: Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease [Phase 1]

View source ↗

Summary

The Phase 1 study of ExoFlo for medically refractory Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• ExoFlo

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Crohn Disease, Inflammatory Bowel Diseases | Phase 1 | Status: TERMINATED